103 related articles for article (PubMed ID: 24289855)
1. Re: use of advanced treatment technologies among men at low risk of dying from prostate cancer.
See WA
Eur Urol; 2014 Jan; 65(1):250. PubMed ID: 24289855
[No Abstract] [Full Text] [Related]
2. Use of advanced treatment technologies among men at low risk of dying from prostate cancer.
Sammon JD; Trinh QD; Menon M
BJU Int; 2014 Aug; 114(2):166-7. PubMed ID: 24180347
[No Abstract] [Full Text] [Related]
3. Re: Effect of age, tumor risk, and comorbidity on competing risks for survival in a u.s. Population-based cohort of men with prostate cancer.
Penson DF
J Urol; 2013 Nov; 190(5):1766-7. PubMed ID: 24120782
[No Abstract] [Full Text] [Related]
4. Re: urologists' use of intensity-modulated radiation therapy for prostate cancer.
Penson DF
J Urol; 2014 May; 191(5):1292. PubMed ID: 24745495
[No Abstract] [Full Text] [Related]
5. Analysis of second malignancies after modern radiotherapy versus prostatectomy for localized prostate cancer.
Huang J; Kestin LL; Ye H; Wallace M; Martinez AA; Vicini FA
Radiother Oncol; 2011 Jan; 98(1):81-6. PubMed ID: 20951450
[TBL] [Abstract][Full Text] [Related]
6. Survey of advanced radiation technologies used at designated cancer care hospitals in Japan.
Shikama N; Tsujino K; Nakamura K; Ishikura S
Jpn J Clin Oncol; 2014 Jan; 44(1):72-7. PubMed ID: 24174632
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiation therapy for prostate cancer.
Jacobs BL; Schroeck FR; Hollenbeck BK
N Engl J Med; 2014 Feb; 370(7):679. PubMed ID: 24521127
[No Abstract] [Full Text] [Related]
8. Intensity-modulated radiation therapy for prostate cancer.
Sartor O; Silberstein JL
N Engl J Med; 2014 Feb; 370(7):679. PubMed ID: 24521126
[No Abstract] [Full Text] [Related]
9. Intensity-modulated radiation therapy for prostate cancer.
Mitchell JM
N Engl J Med; 2014 Feb; 370(7):679-80. PubMed ID: 24521125
[No Abstract] [Full Text] [Related]
10. Re: Certificate of need regulations and the diffusion of intensity-modulated radiotherapy.
Penson DF
J Urol; 2013 Oct; 190(4):1250-1. PubMed ID: 24029317
[No Abstract] [Full Text] [Related]
11. Editorial comment to salvage intensity modulated radiotherapy using endorectal balloon after radical prostatectomy: clinical outcomes.
Fukumori T
Int J Urol; 2013 Dec; 20(12):1183. PubMed ID: 23586499
[No Abstract] [Full Text] [Related]
12. The right therapy for prostate cancer.
Rose CM
Health Aff (Millwood); 2012 Jul; 31(7):1648; author reply 1649. PubMed ID: 22778359
[No Abstract] [Full Text] [Related]
13. Salvage intensity modulated radiotherapy using endorectal balloon after radical prostatectomy: clinical outcomes.
Ishiyama H; Teh BS; Blanco AI; Paulino AC; Mai WY; Caillouet J; Xu B; Butler EB
Int J Urol; 2013 Dec; 20(12):1178-83. PubMed ID: 23573867
[TBL] [Abstract][Full Text] [Related]
14. Low risk, high cost: advanced prostate treatment not always beneficial.
Robeznieks A
Mod Healthc; 2013 Jul; 43(26):16. PubMed ID: 23878904
[No Abstract] [Full Text] [Related]
15. Intensity-modulated radiotherapy: the gold standard for postprostatectomy irradiation?
Bossi A; De Meerleer G; Ost P
Eur Urol; 2011 Dec; 60(6):1149-50; discussion 1150-1. PubMed ID: 21920662
[No Abstract] [Full Text] [Related]
16. Ureteral stenosis after postprostatectomy intensity-modulated radiotherapy.
Cohen KH; Teh BS; Paulino AC; Butler EB
Am J Clin Oncol; 2010 Feb; 33(1):108. PubMed ID: 20139743
[No Abstract] [Full Text] [Related]
17. Patterns of Postprostatectomy Adjuvant Radiotherapy Techniques for Nonmetastatic Prostate Cancer in a Large National Cohort.
Wong AT; Schwartz D; Lee A; Safdieh J; Osborn V; Schreiber D
Clin Genitourin Cancer; 2017 Feb; 15(1):168-175. PubMed ID: 27542509
[TBL] [Abstract][Full Text] [Related]
18. EUS-guided fiducial placement after radical prostatectomy before targeted radiation therapy for prostate cancer recurrence.
Yang J; Abdel-Wahab M; Ribeiro A
Gastrointest Endosc; 2011 Jun; 73(6):1302-5. PubMed ID: 21481860
[No Abstract] [Full Text] [Related]
19. Quality of Life after post-prostatectomy intensity modulated radiation therapy to the prostate bed with or without the use of gold fiducial markers for image guidance or higher total radiotherapy doses.
Abuodeh YA; Naghavi AO; Juan TH; Ma Z; Wilder RB
Int Braz J Urol; 2017; 43(4):628-637. PubMed ID: 28379660
[TBL] [Abstract][Full Text] [Related]
20. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis.
Wallis CJD; Saskin R; Choo R; Herschorn S; Kodama RT; Satkunasivam R; Shah PS; Danjoux C; Nam RK
Eur Urol; 2016 Jul; 70(1):21-30. PubMed ID: 26700655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
